Glaxosmithkline Stock Forecast

Buy or Hold candidate since Jul 09, 2026

No changes to the price of GlaxoSmithKline plc stock on the last trading day (Friday, 10th Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $26.29 to a day high of $26.29. The price has been going up and down for this period, and there has been a 3.79% gain for the last 2 weeks.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $26.87 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -9.07% during the next 3 months and, with a 90% probability hold a price between $20.40 and $24.43 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GLAXF Signals & Forecast

The GlaxoSmithKline plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $26.17 and $25.52. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for GlaxoSmithKline plc stock

GlaxoSmithKline plc finds support from accumulated volume at $26.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.572%

Our recommended stop-loss: $24.74 (-5.88%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (GLAXF) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect GlaxoSmithKline plc to open at $26.29, and during the day (based on 14 day Average True Range), to move between $26.07 and $26.51, which gives a possible trading interval of +/-$0.442 (+/-1.69%) up or down from last closing price. If GlaxoSmithKline plc takes out the full calculated possible swing range there will be an estimated 1.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $26.03 (0.99%) than the resistance at $27.18 (3.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is GlaxoSmithKline plc stock A Buy?

GlaxoSmithKline plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $26.29 ( 0.00000000000001%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk